Skip to main content

Advertisement

Log in

Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Although the synthetic cathinone 4-methylmethcathinone (4-MMC, mephedrone) has been a subject of intensive research investigation, the pharmacological mechanisms involved in its interoceptive stimulus effects have yet to be fully characterized.

Objective

The present study employed drug discrimination methods in rats to compare the interoceptive stimulus properties of two different training doses of 4-MMC to other substances with similar pharmacological actions.

Methods

Sixteen male Sprague-Dawley rats were trained to discriminate either 1.0 mg/kg (N = 8) or 3.0 mg/kg (N = 8) 4-MMC from saline. Substitution tests were conducted with drugs that increase extracellular monoamine levels (d-amphetamine, (+)-methamphetamine, 4-MMC, MDMA, MDPV, and (−)-cocaine), a serotonin releaser (+)-fenfluramine, and a serotonergic (5-HT2A) hallucinogen (+)-LSD.

Results

Stimulus control was established in fewer sessions in the subjects trained with 3.0 mg/kg compared to those trained with 1.0 mg/kg 4-MMC. Cocaine, MDMA, and d-amphetamine produced full substitution in the 1.0 mg/kg 4-MMC-trained rats at doses that did not decrease response rate. However, doses of test drugs that engendered > 80% 4-MMC-lever selection concurrently produced rate-decreasing effects in rats trained to discriminate 3.0 mg/kg 4-MMC.

Conclusions

These findings further characterize the interoceptive stimulus effects of 4-MMC and indicate that these effects vary little with training dose; however, qualitative differences in substitutability of test drugs were observed between training groups. This study expands existing knowledge regarding the psychopharmacology of 4-MMC and the potential neurochemical substrates contributing to its subjective effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aarde SM, Deepshikha A, Barlow DJ et al (2013) Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol 18:786–799. doi:10.1111/adb.12038

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Baumann MH, Ayestas MA, Partilla JS et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192–1203. doi:10.1038/npp.2011.304

    Article  PubMed  CAS  Google Scholar 

  • DeLarge AF, Erwin LL, Winsauer PJ (2017) Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone. Neuropharmacology 119:62–75

    Article  PubMed  CAS  Google Scholar 

  • Drug Enforcement Agency (DEA). (2011, October 21) Schedules of controlled substances: temporary placement of three synthetic cathinones into schedule I. Federal Register, 76(204), 65371–65375. U.S. Government Printing Office, Washington, DC

    Google Scholar 

  • Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones. Behav Pharmacol 24:437–447. doi:10.1016/j.drugalcdep.2014.02.188

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • German CL, Fleckenstein AE, Hanson GR (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97:2–8

    Article  PubMed  CAS  Google Scholar 

  • Hadlock GC, Webb KM, Mcfadden LM et al (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530–536. doi:10.1124/jpet.111.184119

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Harvey EL, Baker LE (2016) Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture. Psychopharmacology 233:673–680. doi:10.1007/s00213-015-4142-4

    Article  PubMed  CAS  Google Scholar 

  • Karlsson L, Andersson M, Kronstrand R, Kugelberg FC (2014) Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic Clin Pharmacol Toxicol 115:411–416. doi:10.1111/bcpt.12253

    Article  PubMed  CAS  Google Scholar 

  • Kehr J, Ichinose F, Yoshitake S et al (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949–1958. doi:10.1111/j.1476-5381.2011.01499.x

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Khorana N, Pullagurla MR, Young R, Glennon RA (2004) Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization. Drug Alcohol Depend 74:281–287. doi:10.1016/j.drugalcdep.2004.01.005

    Article  PubMed  CAS  Google Scholar 

  • Lisek R, Xu W, Yuvasheva E et al (2012) Mephedrone (‘bath salt’) elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126:257–262. doi:10.1016/j.drugalcdep.2012.04.021

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone, and methylone. Br J Pharmacol 167:407–420

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Martinez-Clemente J, Escubedo E, Pubill D, Camarasa J (2012) Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol22:231–236

  • Mayerhofer A, Kovar KA, Schmidt WJ (2001) Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci Lett 308:99–102. doi:10.1016/S0304-3940(01)01992-9

    Article  PubMed  CAS  Google Scholar 

  • Milewski AJ, Rawls S, Walker EA, Saber I (2017) Exploring the pharmacologic and discriminative effects of abused psychostimulants and the bath salt component mephedrone in rats. FASEB J 31:987.10

    Google Scholar 

  • Motbey CP, Clemens KJ, Apetz N et al (2013) High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J Psychopharmacol 27:823–836. doi:10.1177/0269881113490325

    Article  PubMed  CAS  Google Scholar 

  • Stolerman IP, Childs E, Ford MM, Grant KA (2011) Role of training dose in drug discrimination: a review. Behav Pharmacol 22:415–429. doi:10.1097/FBP.0b013e328349ab37

    Article  PubMed  PubMed Central  Google Scholar 

  • Valente MJ, Guedes de Pinho P, de Lourdes BM, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88:15–45. doi:10.1007/s00204-013-1163-9

    Article  PubMed  CAS  Google Scholar 

  • Varner K, Daigle K, Weed P, Lewis P, Mahne S, Sankaranarayanan A, Winsauer P (2013) Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology 225:675–685. doi:10.1007/s00213-012-2855-1

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by a grant from the National Institutes of Health (R15DA038295). The National Institute on Drug Abuse drug control supply program provided several of the test drugs used in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa E. Baker.

Ethics declarations

All procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (2013) and were approved by the Institutional Animal Care and Use Committee at Western Michigan University.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berquist, M.D., Thompson, N.A. & Baker, L.E. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology 234, 3271–3278 (2017). https://doi.org/10.1007/s00213-017-4716-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-017-4716-4

Keywords

Navigation